bg
L

Lyell Immunopharma (LYEL)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Lyell Immunopharma (LYEL)

Lyell Immunopharma, Inc is a T cell reprogramming company. The Company offers T cells to cure patients with solid tumors. Its technologies are designed to be applied in a target and agnostic manner to chimeric antigen receptor (CAR), tumor-infiltrati... Read more

  • USD1.98
  • USD2.05
  • USD1.93
  • USD3.97
  • -28.40%
  • 0M
  • 855.34k
  • 488M
  • 1.32
  • -6.80%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.